Charles River launches ‘strategic review’ alongside activist investor Elliott

Charles River Laboratories is set to start a strategic review and add four new board members after it settled on a “cooperation agreement” with Elliott Investment Management. The Wednesday announcement comes as the FDA said ...

Related Posts

Preventive health startup Superpower raises $30M

Apr 22, 2025  0

J&J reports durability data for bladder cancer 'pretzel...

Apr 26, 2025  0

Degradation startup raises $39M for pivot to PROTACs an...

May 6, 2025  0

Comments

Name

Email

Comment

Post Comment